BioNxt Solutions Inc. (BNXT.CN)
CAD 0.45
(2.22%)
CAD 0.45
(2.22%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.55 Million CAD | 14.1% |
| 2022 | 5.74 Million CAD | -28.75% |
| 2021 | 8.05 Million CAD | 88.34% |
| 2020 | 4.27 Million CAD | 83.45% |
| 2019 | 2.33 Million CAD | 99.37% |
| 2018 | 1.16 Million CAD | 25982.76% |
| 2017 | 4485.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 6.91 Million CAD | 5.62% |
| 2024 Q2 | 7.2 Million CAD | 4.2% |
| 2023 Q1 | 5.53 Million CAD | -3.58% |
| 2023 Q3 | 5.94 Million CAD | 3.19% |
| 2023 FY | 6.55 Million CAD | 14.1% |
| 2023 Q4 | 6.55 Million CAD | 10.11% |
| 2023 Q2 | 5.76 Million CAD | 4.14% |
| 2022 Q3 | 6.56 Million CAD | -7.07% |
| 2022 Q1 | 8.1 Million CAD | 0.63% |
| 2022 FY | 5.74 Million CAD | -28.75% |
| 2022 Q4 | 5.74 Million CAD | -12.61% |
| 2022 Q2 | 7.06 Million CAD | -12.82% |
| 2021 Q3 | 4.11 Million CAD | 5.33% |
| 2021 Q1 | 3.92 Million CAD | -8.29% |
| 2021 FY | 8.05 Million CAD | 88.34% |
| 2021 Q4 | 8.05 Million CAD | 95.8% |
| 2021 Q2 | 3.9 Million CAD | -0.43% |
| 2020 FY | 4.27 Million CAD | 83.45% |
| 2020 Q1 | 3.47 Million CAD | 49.06% |
| 2020 Q2 | 2.3 Million CAD | -33.73% |
| 2020 Q4 | 4.27 Million CAD | 95.95% |
| 2020 Q3 | 2.18 Million CAD | -5.23% |
| 2019 Q1 | 1.39 Million CAD | 19.22% |
| 2019 FY | 2.33 Million CAD | 99.37% |
| 2019 Q4 | 2.33 Million CAD | -7.85% |
| 2019 Q3 | 2.53 Million CAD | 101.76% |
| 2019 Q2 | 1.25 Million CAD | -10.06% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | 1.16 Million CAD | 25982.76% |
| 2018 Q4 | 1.16 Million CAD | 417.32% |
| 2018 Q3 | 226.12 Thousand CAD | 0.0% |
| 2017 FY | 4485.00 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -123.062% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 54.255% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -1291.523% |
| The BC Bud Corporation | 626 Thousand CAD | -946.354% |
| CordovaCann Corp. | 11.29 Million CAD | 41.987% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 22.948% |
| Captor Capital Corp. | 28.76 Million CAD | 77.228% |
| City View Green Holdings Inc. | 3.73 Million CAD | -75.469% |
| 1CM Inc. | 9.42 Million CAD | 30.492% |
| Global Hemp Group Inc. | 5.82 Million CAD | -12.447% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 69.065% |
| IM Cannabis Corp. | 35.11 Million CAD | 81.345% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -166.31% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 35.024% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -2438.845% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | -48.755% |
| Ovation Science Inc. | 728.99 Thousand CAD | -798.531% |
| Pharmadrug Inc. | 2.92 Million CAD | -123.903% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -213.564% |
| RAMM Pharma Corp. | 2.83 Million CAD | -131.007% |
| RIV Capital Inc. | 275.63 Million CAD | 97.624% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | -92.431% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 98.204% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 82.571% |
| 1933 Industries Inc. | 23.28 Million CAD | 71.867% |
| Red Light Holland Corp. | 3.82 Million CAD | -71.397% |
| Top Strike Resources Corp. | 20.99 Million CAD | 68.8% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -729.189% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 62.904% |